Posted by pbd-admin
CV6 Therapeutics
Bob Comfort is the Honorary Consul, Washington State, for the Grand Duchy of Luxembourg. He was the Chief Tax Officer at Amazon.com, a position he held from 2000 until 2011. During his tenure at Amazon, the tax department grew from a staff of three professionals in Seattle to a fully capable team of nearly 100 […]
Posted by pbd-admin
CV6 Therapeutics
Dr. Karl Mulligan has over 20 years of experience in oncology research, diagnostics, and life sciences commercialization. He is the Co-Founder and Chief Operating Officer of CV6 Therapeutics (NI) Ltd., where he has led operations since the company’s inception in 2014, overseeing the strategic development and advancement of novel therapeutics in oncology and inflammatory diseases. […]
Posted by pbd-admin
CV6 Therapeutics
Dr Robert D. Ladner, PhD is the Chief Executive Officer and Founder of CV6 Therapeutics and a leading translational cancer scientist with over two decades of experience in oncology drug development. In 2015, he was appointed Reader in the School of Medicine, Dentistry and Biomedical Sciences at Queen’s University Belfast, where he has been instrumental […]
